How a Rs 72 lakh drug for a rare genetic disease could cost just Rs 3,000
Drug cost analysis expert reveals that the life-saving drug Risdiplam, used to treat the rare genetic disease SMA, could actually be produced for just Rs 3,000 per year in India, compared to its current price of Rs 72 lakh annually.
